Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and tumor genomic testing and precision medicine, announced that the United States Patent and ...

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

Myriad continues to develop its Precise MRD assay to meet the needs of patients with cancer, academic partners, and biopharma ...

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 ...

By Type, the Reagents and Consumables segment dominated the market contributing to 40% of Sanger sequencing market share in 2023. This domination is due to the repeated requirement for reagents like ...

In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs ...

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

One to twenty-four samples can be processed in a single run to isolate free-circulating DNA from fetal-originated DNA in ...

DNA sequencing is any chemical, enzymatic or technological procedure for determining the linear order of nucleotide bases in DNA. Sanger sequencing by replicative synthesis in the presence of ...

Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the ...

Changchun Institute of Optics, Fine Mechanics and Physics, Chinese Academy of Sciences, Changchun 130033, P. R. China University of Chinese Academy of Sciences, Beijing 100049, P. R. China State Key ...

If you'd like to learn more about your health, heritage and family history, an at-home DNA test can help you do just that. Justin Jaffe is the Managing Editor for CNET Money. He has more than 20 ...